• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy
    Follow us on Twitter

      FDA Accepts Glenmark's Review Plea for Painkiller

      Posted AtOnline.wsj.com

      BANGALORE -- Glenmark Pharmaceuticals Ltd. said Wednesday the U.S. Food & Drug Administration has accepted for review a new drug application for painkiller oxycodone hydrochloride capsules and liquid solution, which could potentially be a significant revenue earner for the Indian drug maker.

      The application to the FDA was made earlier by Glenmark's partner in the U.S., Lehigh Valley Technologies.

      The painkiller is part of a "grandfathered products" list, which includes drugs that have been available in the U.S. before the current food and drug regulations came into force in 1938 and which are still being sold today, despite not technically having the FDA approval.

      Since 2006, the regulator has changed its policy towards these "grandfathered products". Once a company seeks and receives regulatory approval to make and sell these products, it must remove other versions of the drug from the market--even if they have been on sale, legally, for years.

      U.S. sales for oxycodone hydrochloride capsules and liquid solution in the year ending December 31, 2009, were $16 million as reported by market research firm IMS Health.

      Under current rules, Glenmark could get an FDA approval within 10 months.

      If the company is able to get a regulatory approval, the drug could boost the company's topline in the financial year starting April 1, 2011, Glenmark Chief Executive and Managing Director Glenn Saldanha told television news channel CNBC-TV18.

      Mr. Saldanha said also that the drug could generate "pretty substantial" operating margins.

      April 07, 2010


       

      Share this Article!

    Back to top^